You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 19, November 19, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Policy Perspectives
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (30)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Medicaid Managed Care and High Quality

Can We Have Both?

Arnold M. Epstein, MD, MA

JAMA. 1997;278(19):1617-1621.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

MEDICAID HAS EMBARKED on a major transition. Accelerating cost pressures in recent years have prompted states to initiate large-scale conversion of their Medicaid programs from traditional fee-for-service coverage to managed care. As a result, the number of Medicaid enrollees cared for in managed care has increased from approximately 2.5 million in 1991 to more than 13 million in June 1996.1 Most of the enrollees have been from the nondisabled, nonelderly, Aid for Dependent Children/Temporary Assistance for Needy Families population.2 The fastest growth has been in fully capitated plans, which now care for approximately 70% of the Medicaid managed care market.3

Growth of managed care for those who are privately insured has led to substantial controversy because of the financial disincentives for managed care organizations to provide sufficient medical services when these lead to increased costs. The potential impact of these disincentives on quality of care is arguably . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Health Policy and Management, Harvard School of Public Health, the Division of General Medicine (Section on Health Services and Policy Research), Brigham and Women's Hospital, and the Department of Health Care Policy, Harvard Medical School, Boston, Mass.


Footnotes

Reprints: Arnold M. Epstein, MD, MA, Department of Health Policy and Management, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115 (e-mail: aepstein@hsph.harvard.edu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Medication Dispensing and Medicaid Managed Care
Dean Schillinger, David Ofman, and Arnold M. Epstein
JAMA. 1998;279(12):912-913.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.